Health Economics and Outcomes Research

Using a cost-effectiveness model, researchers compared 4 different chemotherapy combinations for advanced, persistent,or recurrent cervical cancer. 
A study has called into question how the Food and Drug Administration (FDA) uses surrogate endpoints in approvals for certain cancer medications.
Researchers conducted a retrospective cohort study of patients aged 60 years and older treated for esophageal cancer at an academic treatment facility in China to assess nutritional status affected survival. 
Researchers used data from IMS Health to look at how cancer drug pricing and treatment utilization have changed over a 10-year period from 2004-2014 in nine countries.
Scott Glaser, MD, presented results from a study evaluating chemotherapy and radiation therapy in the largest group of patients with stage 2 testicular seminoma ever recorded. 
Investigators published the long-term results of a clinical trial evaluating the effect of adding chemotherapy to radiation on outcomes for patients with brain cancer. 
Researchers compared the clinical and economic benefits of co-testing with HPV primary using a hypothetical cohort of 1 million 30-year-old women modeled up to age 70 years.